Jabbour, E., Sandhu, K. S., Shaughnessy, P., Logan, A. C., Abedi, M., Shah, B. D., Bishop, M. R., Park, J. H., DeAngelo, D. J., Tholouli, E., Yallop, D., Chaganti, S., Hodby, K., Barba, P., Guerreiro, M., Menne, T., Shang, J., Lao-Sirieix, P., Brugger, W. and Roddie, C. (2020) “Tumor burden-guided dosing contributes to mitigation of immunotoxicities following treatment with obecabtagene autoleucel in adult patients with relapsed/refractory B-cell acute lymphoblastic leukemia”, Haematologica. Pavia, Italy. doi: 10.3324/haematol.2025.288587.